LEADER 02525nam  2200565   450 
001 9910459739103321
005 20200520144314.0
010   $a0-309-28811-8
035   $a(CKB)3710000000229408
035   $a(EBL)3379351
035   $a(SSID)ssj0001424118
035   $a(PQKBManifestationID)12547907
035   $a(PQKBTitleCode)TC0001424118
035   $a(PQKBWorkID)11446912
035   $a(PQKB)10353878
035   $a(MiAaPQ)EBC3379351
035   $a(Au-PeEL)EBL3379351
035   $a(CaPaEBR)ebr10924429
035   $a(OCoLC)899280083
035   $a(EXLCZ)993710000000229408
100   $a20140912h20142014  uy             0
101 0 $aeng
135   $aurcnu||||||||
181   $ctxt
182   $cc
183   $acr
200 10$aImproving access to essential medicines for mental, neurological, and substance use disorders in Sub-Saharan Africa $eworkshop summary : forum on neuroscience and nervous system disorders /$fBoard on Health Sciences Policy, Board on Global Health ; Diana E. Pankevich, rapporteurs [and three others]
210  1$aWashington, District of Columbia :$cThe National Academies Press,$d2014.
210  4$dİ2014
215   $a1 online resource (143 p.)
300   $aDescription based upon print version of record.
311   $a0-309-28810-X 
327   $a""Front Matter""; ""Reviewers""; ""Contents""; ""1 Introduction and Overview""; ""2 Challenge: Insufficient Demand""; ""3 Challenge: Inappropriate Selection""; ""4 Challenge: Ineffective Supply Chains""; ""5 Challenge: High Pricing and Poor Financing""; ""6 Perspectives on Next Steps""; ""Appendix A: Access to Essential Medicines: Program Examples""; ""Appendix B: References""; ""Appendix C: Workshop Agenda""; ""Appendix D: Registered Attendees""
606   $aPsychology, Pathological$xdrug therapy
606   $aNervous System Diseases$xdrug therapy$vCongresses
606   $aMental illness$xdrug therapy
608   $aElectronic books.
615  0$aPsychology, Pathological$xdrug therapy.
615  0$aNervous System Diseases$xdrug therapy
615  0$aMental illness$xdrug therapy.
676   $a616.8918
702   $aPankevich$b Diana E.
712 02$aInstitute of Medicine (U.S.).$bBoard on Global Health,
801  0$bMiAaPQ
801  1$bMiAaPQ
801  2$bMiAaPQ
906   $aBOOK
912   $a9910459739103321
996   $aImproving access to essential medicines for mental, neurological, and substance use disorders in Sub-Saharan Africa$92118864
997   $aUNINA